Unpacking the Mounjaro Pen: Is There a 5th Dose in Mounjaro Pen?

Last reviewed: July 17, 2026

Last updated: July 17, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Mounjaro pens are designed with four pre-filled, once-weekly injection doses in each pen device. Many patients wonder about dose counts because the titration schedule spans multiple weeks, which can create confusion about how many injections come in a single package. PlexusDx compounded tirzepatide injections offer the same active ingredient with flexible dosing and transparent pricing regardless of your dose level.

Mounjaro Pen Dose Count and Design

Each Mounjaro pen contains exactly four pre-filled doses of tirzepatide, a dual GLP-1 and GIP receptor agonist. The pen is mechanized to deliver 0.5 mL per injection, and once all four doses are used, the device is discarded and replaced with a new pen. This design means patients receive one month of weekly injections per pen, then require a new pen for continued treatment.

The four-dose structure aligns with once-weekly dosing for standard titration protocols. Patients typically start at 2.5 mg, then increase by 2.5 mg increments weekly until reaching their maintenance dose, which commonly falls between 10 mg and 15 mg per week. Each pen accommodates this progression without waste, though some patients may need partial weeks of lower doses depending on their individual treatment timeline.

How Tirzepatide Dosing Works in Clinical Practice

Tirzepatide dosing follows a predictable escalation schedule designed to minimize gastrointestinal side effects while building therapeutic effect. The standard approach begins with a 2.5 mg dose in week one, increases to 5 mg in week two, 7.5 mg in week three, and continues upward depending on tolerability and weight loss response. Most individuals reach stable weight loss at 10 mg to 15 mg weekly, though some benefit from higher maintenance doses under medical supervision.

The titration period typically lasts 4 to 8 weeks before stabilizing at maintenance. During this time, users experience progressive appetite suppression and improved metabolic signaling through dual pathway activation. PlexusDx compounded tirzepatide injections follow identical pharmacokinetic principles as the branded version, allowing seamless transitions between therapies without requiring restart of titration protocols.

Compounded Tirzepatide vs. Brand Name Mounjaro

PlexusDx tirzepatide injections are manufactured by licensed 503A compounding pharmacies using pharmaceutical-grade active ingredients identical to branded Mounjaro. The key difference lies in pricing transparency and accessibility: PlexusDx charges one flat monthly rate of $289 to $289 depending on commitment tier, not based on dose level. Your dose may need to go up. Your price won't.

Compounded tirzepatide offers several practical advantages for long-term weight management. No insurance is required, making it accessible across all 50 states and HSA/FSA eligible for tax-advantaged health savings. PlexusDx medical providers adjust your dose independently of refill scheduling, eliminating the need to purchase new pens when your maintenance dose stabilizes.

Personalizing Your Tirzepatide Treatment With Genetic Insights

Individual response to tirzepatide varies significantly based on genetic predispositions affecting peptide pathway sensitivity. PlexusDx Precision Peptide Genetic Test identifies key variants including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 that influence how your body responds to dual GLP-1/GIP activation. This $298 test maps 14 metabolic pathways and 150+ genetic insights to inform personalized dosing strategy.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test ($298) to personalize your protocol from day one.

Frequently Asked Questions

Does Mounjaro pen really have only 4 doses?

Yes, each Mounjaro pen contains exactly four pre-filled doses of tirzepatide, delivering one dose per week for one month. PlexusDx compounded tirzepatide eliminates the hassle of pen tracking by providing monthly refills at flat pricing, so you don't pay more as your dose increases.

Can I use a partial pen and save it for later?

Mounjaro pens are single-use devices and cannot be saved after initial use; the needle retracts and the device locks after each dose. PlexusDx compounded tirzepatide offers more flexibility—your provider can adjust weekly doses without forcing you to buy a new pen, and unused medication does not expire within your treatment month.

What happens if I need more than 4 doses in a month?

Standard tirzepatide dosing is once weekly, so four doses per month aligns perfectly with normal schedules. If you require interim dose adjustments during titration, PlexusDx providers can deliver custom doses without purchasing extra pens, at $289/mo month-to-month, or from $249/mo on the 6-month plan flat rate regardless of dose level.

Are compounded tirzepatide injections as effective as Mounjaro?

PlexusDx compounded tirzepatide uses identical pharmaceutical-grade active ingredients, so efficacy and metabolic mechanism are equivalent. The difference is cost transparency, accessibility across all states without insurance, and personalized dosing based on your individual peptide pathway genetics through the Precision Peptide Genetic Test.

How does the Precision Peptide Genetic Test help with tirzepatide dosing?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Hers Mounjaro
• Hims Mounjaro
• Mounjaro For Hypertension
• Mounjaro For Endometriosis

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.